![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, May 25, 2012 6:56:30 AM
As I have posted many times my strategy is to "Buy, Accumulate, and Hold" ALL of my Elite shares. I have NEVER flipped a single share of ELTP. Nor do I ever intend to.
I will continue to buy additional ELTP shares on every PPS pull-back which IMO are caused by the MMs/Trellus Naked/Covered Shortings. It is very obvious from the T&S trading records that these Shortings have been prevalant in the past and especially since the ELI-216 Patent publication on Tues May 22. By doing so the MMs/Trellus hope to entice flippers. The MMs/Trellus purpose is the destruction of Elite. That is why the PPS went from $ to pennies leading to the 2009 hostile take over strategy of Trellus. Thank goodness for Jerry's Treppel's savvy leadership and his alliance with Epic to thwart Trellus.
The MMs/Trellus traders will continue to inflict as much pain as they can. However each day more shares are removed from circulation by the Longs as the PPS continues to move up. Yes it is "2 steps up and 1 step back" but it is up 43% YTD from $0.09 to $0.129.
Each day Elite's cash flow is increasing through (1)increasing market sales of their launched drugs and (2)increasing lab revenues from their contracted consulting R&D. The 2 additional hirings, 10% increased to +20 employees, tells exactly the increasing cash flow facts. Each day brings Elite closer to additional ANDA drug launches and in 2013, with FDA approval, the ELI-216 NDA launch.
I hope Longs will continue to join in the "Buy, Accumulate, and Hold" strategy for continuing PPS increases.
GLTA Longs.
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:07:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 08:30:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:55:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 07:21:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 09:20:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:20:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 12:05:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:58:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:50:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with ZenaDrone • InvestorsHub NewsWire • 11/16/2023 12:32:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2023 08:15:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 08:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 09:30:05 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 07/31/2023 08:20:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2023 08:15:16 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM